Aramic LLC v. Revance Therapeutics, Inc.
Opinion
Trial Court Opinion
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 ARAMIC LLC, et al., Case No. 21-cv-09585-AMO
Plaintiffs,
ORDER GRANTING DEFENDANTS’
v. MOTION TO STRIKE AND MOTION
TO DISMISS
REVANCE THERAPEUTICS, INC., et al., Re: Dkt. Nos. 91, 92 Defendants.
12 This is a securities fraud case about the U.S. Food and Drug Administration’s review of a drug developed by Revance Therapeutics, Inc. (“Revance”). Before the Court are Defendants’ motion to strike a declaration attached as an exhibit to Plaintiffs’ second amended complaint (“SAC”) and Defendants’ motion to dismiss Plaintiffs’ SAC. The matters are fully briefed and suitable for decision without oral argument. See Civil L.R. 7-6. Having read the papers filed by the parties and carefully considered their arguments and the relevant legal authority, the Court hereby GRANTS both motions for the following reasons. I. BACKGROUND Plaintiffs Aramic LLC and Tang Family Investor Group (collectively, “Lead Plaintiffs”) are stockholders of…